menu
    • menu
    [{"orgOrder":0,"company":"Seoul National University Hospital","sponsor":"Boryung Pharmaceutical Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"SOUTH KOREA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Sodium Selenite","moa":"Selenoprotein","graph1":"Neurology","graph2":"Phase III","graph3":"Seoul National University Hospital","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Seoul National University Hospital \/ Boryung Pharmaceutical Co., Ltd","highestDevelopmentStatusID":"10","companyTruncated":"Seoul National University Hospital \/ Boryung Pharmaceutical Co., Ltd"},{"orgOrder":0,"company":"RWTH Aachen University","sponsor":"BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"GERMANY","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Sodium Selenite","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"RWTH Aachen University","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"RWTH Aachen University \/ BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung","highestDevelopmentStatusID":"10","companyTruncated":"RWTH Aachen University \/ BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung"},{"orgOrder":0,"company":"Daren K. Heyland","sponsor":"BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Sodium Selenite","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Daren K. Heyland","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Catheter","sponsorNew":"Daren K. Heyland \/ BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University","highestDevelopmentStatusID":"10","companyTruncated":"Daren K. Heyland \/ BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University"}]

    Find Clinical Drug Pipeline Developments & Deals for Sodium Selenite

    Menu

    Sodium Selenite

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Seoul National University Hospital

                            South Korea arrow
                            ACI Convention
                            Not Confirmed

                            Seoul National University Hospital

                            South Korea arrow
                            ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : Boryung Pharmaceutical Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy

                            Details : Sodium Selenite Pentahydrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Chemotherapy-induced Peripheral Nervous System Diseases.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            December 17, 2019

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : Boryung Pharmaceutical Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            RWTH Aachen University

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            RWTH Aachen University

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            High-dose Selenium Supplementation in Patients With Left Ventricular Assist

                            Details : Sodium Selenite is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Ventricular Dysfunction, Left.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 21, 2015

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Daren K. Heyland

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Daren K. Heyland

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).

                            Details : Sodium Selenite is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Diseases.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 05, 2013

                            Lead Product(s) : Sodium Selenite

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth